Moderna and AstraZeneca involved in COVID vaccine donation program
Moderna (NASDAQ: MRNA) will provide 34 million doses of its Covid-19 vaccine this year and Sweden has donated one million doses of AstraZeneca (NASDAQ: AZ) to the global COVAX program, a little push then that she struggles to obtain stocks to inoculate the poorest in the world.
The advance purchase agreement with Moderna is for 500 million doses, but deployment will not begin until the fourth quarter, with 34 million doses available this year, the GAVI vaccine alliance announced on Monday.
The bulk – 466 million – would not be available until next year, he said.
The agreement brings the program’s vaccine portfolio to eight and contains options for potentially accessing vaccine doses suitable for variants in the future, he said.
The deal follows WHO’s approval on Friday of the US drugmaker’s emergency drug list, a prerequisite for COVAX eligibility.
GAVI manages the COVAX vaccine sharing center with the World Health Organization.
The Swedish donation is the second from a European Union member after France last month amid growing concerns over growing inequality in vaccine distribution after wealthy countries stockpiled vaccines for their citizens .
The EU also wants the bloc to resume the initiative for vaccine diplomacy from Russia and China.
Sweden suspended use of the AstraZeneca vaccine in March after reports of rare but serious blood clots in people who had received the injection. He later resumed the use of shot, but only for people aged 65 or over.
Shares of MRNA were up $ 9.17, or 5.1%, to $ 187.99, while those of AZ were up 17 cents to $ 53.24.